pharmaphorum

J&J bets on Isomorphic for AI-powered drug hunt

Under the terms of the J&J deal, Isomorphic will be responsible for in silico predictions and design, while the US group will ...
Benzinga.com

Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery

Isomorphic Labs, a London-based spin-out of Alphabet Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) Google's AI R&D division DeepMind, has announced strategic partnerships with Eli Lilly And Co (NYSE:LLY) and ...
SiliconANGLE

Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine

Isomorphic Labs Inc., a healthcare startup that spun out of Alphabet Inc. in 2021, today announced that it has closed a $600 million funding round. OpenAI backer Thrive Capital led the investment. It ...
The New York Times

Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer. By Michael J. de la Merced Reporting from London Over the ...
FierceBiotech

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM

Just more than two years after launching within Alphabet, Isomorphic has inked two large pharma deals with Eli Lilly and Novartis with nearly $3 billion in combined deal value. The two separate pacts ...